Best in Biotech 22 Jan 2025
Curing ALS? Sixteen companies developing new treatments in 2025
Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.
- Latest Posts
Best in Biotech 21 Jan 2025
14 biotech podcasts to tune into in 2025
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.
In Depth 20 Jan 2025
Is biotech M&A set to surge in 2025?
There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play.
In Depth 17 Jan 2025
Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?
Podcast 17 Jan 2025
Venture capital co-creation: The next big thing in biotech investment?
This week, we talked with Jessica Owen, co-founder of Initiate Ventures, a venture firm with an interesting dual model.
News and Trends 16 Jan 2025
Top biotech deals of December 2024
The month of December saw a variety of biotech deals take place to advance therapies across different stages in development.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 16 Jan 2025
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.
In Depth 15 Jan 2025
CRISPR: The gene editing tool changing the world (2025 update)
CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential?
Best in Biotech 14 Jan 2025
Singapore’s biotech scene: 7 companies leading the way in 2025
Discover seven of the top biotech companies in Singapore – a country that set out to become a global biotech hub just over 20 years ago.
In Depth 13 Jan 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.
News and Trends 10 Jan 2025
The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy
A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.
Podcast 10 Jan 2025
Fighting pain with non-opioid drugs
In the first episode of 2025, we talk about non-opioid pain drugs with Brixton Biosciences.
ADVERTISEMENT
